Funding New Spinouts & Backing an Industry Leader
We work closely with our partner laboratories to identify commercial opportunities arising from their...read more
In recognition of our Fund’s widening reach to build world-leading companies from world-leading UK science, as of January 2018, we have changed our name from Rainbow Seed Fund to UK Innovation & Science Seed Fund (UKI2S).
As a leading patient capital investor with more than £330 million private investment leveraged to date, we will continue our work to shape and build technology companies at the earliest stage by working closely with our partners led by STFC, BBSRC, NERC, Dstl — with the National Research and Innovation Campuses they support, and with entrepreneurial science-led teams.
UKI2S also remains closely aligned with the Catapults, InnovateUK and the developing UK Research & Innovation (UKRI) to create the best environment for innovation to flourish and in turn, boost the UK’s competitiveness and productivity by commercialising key technological advances in industrial biotech, ag tech, healthcare, medicine, clean energy, materials, artificial intelligence, software and space.
We will soon announce a number of newly-funded portfolio companies as part of InnovateUK’s £8.5 million investment accelerator pilot, a pivotal partnership that joins InnovateUK grants with venture capital to help bridge the gap between R&D and commercialisation.
In short, it is an exciting time for the Fund as we expand our position to invest in the incredible innovations emerging from the UK’s science base. Follow updates here on our new website and also via Twitter — our new handle is @UKI2S.